This is our biggest victory, yet!
Earlier this month, Solve M.E. led the charge for federally funded research into Long-COVID and myalgic encephalomyelitis (ME) — previously known as chronic fatigue syndrome (CFS). We authored this letter, joined by 20 leading chronic disease and health equity stakeholders, and met with dozens of legislators to discuss these federal funding needs. Our message was a warning and call to action about the increasing number of COVID-19 patients experiencing post-viral complications like ME/CFS.
Our message was heard! This weekend, Congress approved $1.15 billion for Long-COVID research and clinical trials, with $100 million specifically used for the Rapid Acceleration of Diagnostics. The funds will remain available to the NIH until September 30, 2024.
We succeeded because of you! This achievement would not have happened without your support. We are so grateful for your passion in advocating for ME/CFS!
Additional details about the complex weekend budget agreements are slowly emerging from Congress. We’ll have a full ME/CFS budget breakdown for you in the coming weeks.
But we know the fight is not over – we must ensure this $1.15 billion is spent on quality research that will transform our understanding of ME/CFS and post-viral illness and improve the quality of life for millions. Your voice and your support is needed more than ever. Please consider making a gift of any amount to Solve M.E. this holiday season to strengthen our advocacy program next year.
